Related Experiment Video
Updated: Feb 16, 2026

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
Remote Ischemic Preconditioning has a Cardioprotective Effect in Children in the Early Postoperative Phase: A
Wen Tan1, Chaoji Zhang1, Jianzhou Liu1
1Department of Cardiac Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.
Insights
Remote ischemic preconditioning (RIPC) shows cardioprotective effects in pediatric patients undergoing heart surgery. This method reduces cardiac enzyme release and shortens recovery times, including ventilator support and ICU stay.
Area of Science:
- Cardiology
- Pediatric Surgery
- Critical Care Medicine
Background:
- Congenital heart surgery in pediatric patients carries significant risks.
- Identifying effective cardioprotective strategies is crucial for improving outcomes.
- Remote ischemic preconditioning (RIPC) is a potential non-invasive intervention.
Purpose of the Study:
- To evaluate the cardioprotective efficacy of RIPC in pediatric patients undergoing congenital heart surgery.
- To synthesize evidence from randomized controlled trials (RCTs) on RIPC's impact on postoperative markers and recovery.
- To assess the benefits of RIPC in the early postoperative phase.
Main Methods:
- An updated meta-analysis was conducted.
- Included 9 randomized controlled trials (RCTs) with a total of 793 pediatric patients (<18 years).
- Analyzed data on troponin I release, inotropic scores, ventilator support, and ICU stay duration.
Main Results:
- RIPC significantly reduced troponin I release 6 hours post-surgery (SMD -0.59, p=0.03).
- RIPC mitigated inotropic scores at 4-6 hours (SMD -0.43, p=0.004) and 12 hours (SMD -0.26, p=0.03).
- RIPC shortened ventilator support time (SMD -0.28, p=0.01) and ICU stay (SMD -0.21, p=0.004).
Conclusions:
- Remote ischemic preconditioning demonstrates significant cardioprotective effects in pediatric patients post-congenital heart surgery.
- RIPC positively impacts early postoperative recovery markers and resource utilization.
- Further RCTs are warranted to explore the long-term cardiac benefits of RIPC in this population.
Abstract:
In this updated meta-analysis, we assessed the cardioprotective effect of remote ischemic preconditioning (RIPC) in pediatric patients undergoing congenital heart surgery. A total of 9 randomized controlled trials (RCTs) involving 793 pediatric patients under 18 years old were identified. RIPC obviously reduced the release of troponin I at 6 h after surgery [standard mean difference (SMD) -0.59, 95% confidence interval (CI) -1.14 to -0.04; p = 0.03], mitigated the inotropic scores within 4-6 h (SMD -0.43, 95% CI -0.72 to -0.14; p = 0.004) and within 12 h (SMD -0.26, 95% CI -0.50 to -0.02; p = 0.03) and shortened the ventilator support time (SMD -0.28, 95% CI -0.49 to -0.07; p = 0.01) as well as the duration of intensive care unit (ICU) stay (SMD -0.21, 95% CI -0.35 to -0.06; p = 0.004). Our meta-analysis determined that RIPC had cardioprotective effects in the early postoperative phase. Additional RCTs focused on the cardiac benefits from RIPC in pediatric patients are warranted.
More Related Videos
Related Concept Videos
Phase-lead and Phase-lag Controllers
Statistical Software for Data Analysis and Clinical Trials
Time and frequency -Domain Interpretation of Phase-lead Control
The design of phase-lead control involves the strategic placement of poles and zeros to balance steady-state error and system...
Time and frequency -Domain Interpretation of Phase-lag Control
Phase-lag controllers do not place a pole at zero, but instead influence the steady-state error by amplifying any...
Trial and Error and Algorithm
Clinical Trials: Overview

